0001144204-11-040430.txt : 20110713 0001144204-11-040430.hdr.sgml : 20110713 20110713193155 ACCESSION NUMBER: 0001144204-11-040430 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110622 FILED AS OF DATE: 20110713 DATE AS OF CHANGE: 20110713 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001114220 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 134087132 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 750 LEXINGTON AVENUE STREET 2: . CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-531-5965 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fowler Wyche JR CENTRAL INDEX KEY: 0001381064 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30929 FILM NUMBER: 11966679 MAIL ADDRESS: STREET 1: KERYX BIOPHARMACEUTICALS, INC. STREET 2: 750 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 4 1 v228526_ex.xml X0303 4 2011-06-22 0 0001114220 KERYX BIOPHARMACEUTICALS INC KERX 0001381064 Fowler Wyche JR KERYX BIOPHARMACEUTICALS, INC. 750 LEXINGTON AVENUE NEW YORK NY 10022 1 0 0 0 Common Stock 2011-06-22 4 A 0 15000 0 A 120000 D Stock Options (Right to Buy) 4.38 2011-06-22 4 A 0 25000 0 A 2012-06-22 2021-06-22 Common Stock 25000 25000 D One third of the shares of restricted stock vest on 06/22/2012; one third vest on 06/22/2013; and one third vest on 06/22/2014. Of the 120,000 shares, 25,000 shares are restricted common stock. One third of the stock options vest on 06/22/2012; one third vest on 06/22/2013; and one third vest on 06/22/2014. /s/ James F. Oliviero, Attorney-in-Fact 2011-07-13